Tradestie Institutional Equity Comparison Engine

MAZE vs MLTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAZE Overall Edge

MAZE Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Maze Therapeutics, Inc. Common Stock (MAZE) driven by superior Valuation, Momentum & Technical, Options & Structure while MLTX counters with relative strength in Growth & Margin. Fundamentally, MAZE trades at 8.5x Forward P/E with -820.8% operating margin (+0.0% YoY revenue) versus MLTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MAZE sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MAZE
MAZE 8.5x vs MLTX N/M Fwd P/E
Growth & Margin Winner MLTX
Op Margin -820.8% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner MAZE
1Y +7.3% vs -5.7% ยท 52W Pos 38% vs 17%
Options & Structure Winner MAZE
UNCLASSIFIED (3rd %ile IV) vs BREAKDOWN (7th %ile IV)
MAZE NASDAQ
Maze Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$34.16
-0.5% 1D
Market Cap $2.0B
1M Return +24.08%
1Y Return +7.29%
Forward P/E 8.5x
Unified AI Score
34.8 / 100 SELL
Tech 8.0 Fund 30.0 Flow 50.0 Mom 50.0
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MAZE +7.29% MLTX -5.65% Spread: +12.94 pp (MAZE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MAZE TTM Op. Margin: -820.8% MLTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MAZE vs MLTX. Trailing 12-month operating profitability (MAZE -820.8% vs MLTX 0.0%) and valuation multiples (MAZE 8.5x vs MLTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MAZE (6) vs MLTX (2)
Institutional Metric MAZE MLTX Criterion Row Winner
Market Capitalization Scale $2.0B $1.1B Larger Scale MAZE
Trailing P/E Ratio Valuation 8.5x N/M Lower Multiple MAZE
Forward P/E Ratio Valuation 8.5x N/M Lower Multiple MAZE
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -820.8% 0.0% Higher Margin MLTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -37.5% -81.5% Higher ROE MAZE
52-Week Range Position Momentum 38% ($22โ€“$54) 17% ($9โ€“$23) Stronger Trend MAZE
Beta / 30D Volatility Risk Regime 0.78ฮฒ ยท 54% Vol 1.61ฮฒ ยท 90% Vol Lower Realized Risk MAZE
Unified Institutional Score Composite Signal 34.8 / 100 (SELL) 38.3 / 100 (SELL) Higher Composite MLTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MAZE vs MLTX Buy Guide
MAZE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live MAZE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MAZE nor MLTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.